Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· June 8, 2026

3 Asian Stocks That May Be Trading At An Estimated 46.1% To 49.5% Discount

View original at finance.yahoo.com
3 Asian Stocks That May Be Trading At An Estimated 46.1% To 49.5% Discount As Asian markets navigate a complex landscape of economic recovery and geopolitical tensions, investors are increasingly on the lookout for opportunities that may be undervalued amidst these challenges…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • TRIAL Holdings earnings are projected to grow at 30.48% annually over the next three years, surpassing Japan's market growth rate

    60% confidence
  • TRIAL Holdings is significantly undervalued at ¥2,782 compared to its future cash flow estimate of ¥5,503.86, representing a 49.5% discount

    60% confidence
  • TRIAL Holdings fiscal 2026 guidance was revised upward due to effective SG&A cost control and lower non-operating expenses yielding better-than-expected net sales and operating profit

    60% confidence
  • Asian markets are navigating a complex landscape of economic recovery and geopolitical tensions, creating opportunities in undervalued stocks

    60% confidence
  • The Shoucheng Holdings share buyback program aims to enhance net assets and earnings per share, potentially supporting stock value appreciation

    60% confidence
  • Shoucheng Holdings is trading at HK$1.78, significantly below its estimated future cash flow value of HK$3.30, representing a 46.1% discount to fair value

    60% confidence
  • Shoucheng Holdings earnings are forecasted to grow at 48.8% annually over the next three years, outpacing the Hong Kong market's growth rate of 12.8%

    60% confidence
  • Hong Kong market earnings growth rate is 12.8% annually

    60% confidence
  • Shoucheng Holdings profit margins declined from 33.8% to 21.6%

    60% confidence
  • TRIAL Holdings carries a high level of debt and has a volatile share price

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com